RxSight, Inc.

NASDAQ:RXST

33.66 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 89.07749.00522.59314.6782.241
Cost of Revenue 35.31227.67718.07612.9734.06
Gross Profit 53.76521.3284.5171.705-1.819
Gross Profit Ratio 0.6040.4350.20.116-0.812
Reseach & Development Expenses 29.05125.98124.49921.93429.569
General & Administrative Expenses 00000
Selling & Marketing Expenses 00000
SG&A 74.79958.66532.80515.17615.203
Other Expenses 00000
Operating Expenses 103.8584.64657.30437.1144.772
Operating Income -50.085-63.318-52.787-35.405-46.07
Operating Income Ratio -0.562-1.292-2.336-2.412-20.558
Total Other Income Expenses Net 1.497-3.4294.10763.037172.314
Income Before Tax -48.588-66.747-48.6827.632126.244
Income Before Tax Ratio -0.545-1.362-2.1551.88356.334
Income Tax Expense 0.020.0090.0080.0570.024
Net Income -48.608-66.756-48.68827.575126.22
Net Income Ratio -0.546-1.362-2.1551.87956.323
EPS -1.41-2.41-1.780.120.95
EPS Diluted -1.41-2.41-1.780.120.95
EBITDA -41.037-57.779-41.0132.154130.2
EBITDA Ratio -0.461-1.261-2.334-2.102-18.007